Compounds > ampelopsin
Page last updated: 2024-09-04

ampelopsin and Ovarian Neoplasms

ampelopsin has been researched along with Ovarian Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y; Ding, F; Li, B; Li, S; Liu, P; Liu, T; Sun, X; Wang, F; Wang, S; Yu, N; Zhang, X; Zhao, Y1
Chen, X; Luo, Y; Wang, F; Yi, Y; Yuan, D1
Chan, HF; Chen, M; He, C; Lin, Z; Lu, H; Wang, S; Xu, Y1

Other Studies

3 other study(ies) available for ampelopsin and Ovarian Neoplasms

ArticleYear
Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition.
    Oncology reports, 2015, Volume: 33, Issue:2

    Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Flavonoids; Humans; I-kappa B Proteins; Neoplasm Metastasis; NF-kappa B; NF-KappaB Inhibitor alpha; Nitriles; Ovarian Neoplasms; Sulfones; Time Factors; Up-Regulation; Vimentin

2015
Golgi reassembly and stacking protein 65 downregulation is required for the anti-cancer effect of dihydromyricetin on human ovarian cancer cells.
    PloS one, 2019, Volume: 14, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Movement; Down-Regulation; Female; Flavonols; Golgi Matrix Proteins; Humans; MAP Kinase Signaling System; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; Up-Regulation

2019
Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin.
    Scientific reports, 2017, 04-24, Volume: 7

    Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Shape; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Female; Flavonols; Humans; Inhibitor of Apoptosis Proteins; Ovarian Neoplasms; Paclitaxel; S Phase; Signal Transduction; Survivin; Tumor Suppressor Protein p53

2017